© 2023 MJH Life Sciences and Drug Topics. All rights reserved.
© 2023 MJH Life Sciences™ and Drug Topics. All rights reserved.
"""ROCKY MOUNTAIN MOVEMENT DISORDERS CENTER, P.C."""
701 E. HAMPDEN AVE
November 26, 2013
Reevaluation of RECORD trial data fails to uncover elevated cardiovascular risk.
November 15, 2013
Lurasidone HCl (Latuda) reduces depressive symptoms in adult patients with bipolar depression when used as monotherapy and adjunctive therapy to lithium or valproate. This flexibility is important given the multiple unmet needs of patients with bipolar depression, according to two phase 3 studies published recently in The American Journal of Psychiatry.
November 05, 2013
Once-daily dosing of the investigational drug tiotropium helped to improve lung function over 24 hours in individuals with severe asthma, according to data presented at the 2013 American College of Chest Physicians annual meeting (CHEST 2013) in Chicago.
November 01, 2013
FDA has approved obinutuzumab (Gazyva, Genentech, a member of the Roche Group), also known as GA101, in combination with chlorambucil chemotherapy for the treatment of patients with previously untreated chronic lymphocytic leukemia.